Aclaris Therapeutics (ACRS) Change in Account Payables (2014 - 2026)
Aclaris Therapeutics' quarterly Change in Account Payables came in at $1.5 million in Q1 2026, down 9.07% year-on-year from $1.7 million in Q1 2025, and down 61.82% quarter-over-quarter from $4.0 million in Q4 2025.
Aclaris Therapeutics has reported Change in Account Payables for 13 years, with the latest figure at $1.5 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 9.07% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $8.3 million (up 286.18% YoY), and the FY2025 full-year result was $8.4 million, up 301.7% from the prior year.
- Change in Account Payables for Q1 2026 stood at $1.5 million, down from $4.0 million in the prior quarter.
- The five-year high for Change in Account Payables was $4.0 million in Q4 2025, with the low at -$3.5 million in Q2 2024.
- Average Change in Account Payables over 5 years is $274529.4, with a median of $393000.0 recorded in 2024.
- Year-over-year, Change in Account Payables soared 233.79% in 2023 and plunged 654.31% in 2024.
- Tracing ACRS's Change in Account Payables over 5 years: stood at $2.7 million in 2022, then slumped by 114.66% to -$394000.0 in 2023, then sank by 654.31% to -$3.0 million in 2024, then surged by 233.34% to $4.0 million in 2025, then plunged by 61.82% to $1.5 million in 2026.
- The last three Change in Account Payables figures came in at $1.5 million (Q1 2026), $4.0 million (Q4 2025), and $377000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Aclaris Therapeutics | 586.09 Mn | 586.09 Mn | 1.60 Mn | 1.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.51 Mn |
| Mar 31, 2026 | 1.51 Mn |
| Dec 31, 2025 | 3.96 Mn |
| Dec 31, 2025 | 3.96 Mn |
| Sep 30, 2025 | 377,000.00 |
| Sep 30, 2025 | 377,000.00 |
| Jun 30, 2025 | 2.44 Mn |
| Jun 30, 2025 | 2.44 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | -2.97 Mn |
| Dec 31, 2024 | -2.97 Mn |
| Sep 30, 2024 | 393,000.00 |
| Sep 30, 2024 | 393,000.00 |
| Jun 30, 2024 | -3.54 Mn |
| Jun 30, 2024 | -3.54 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Dec 31, 2023 | -394,000.00 |
| Dec 31, 2023 | -394,000.00 |
| Sep 30, 2023 | -2.15 Mn |
| Sep 30, 2023 | -2.15 Mn |
| Jun 30, 2023 | 3.24 Mn |
| Jun 30, 2023 | 3.24 Mn |
| Mar 31, 2023 | -2.16 Mn |
| Mar 31, 2023 | -2.16 Mn |
| Dec 31, 2022 | 2.69 Mn |
| Dec 31, 2022 | 2.69 Mn |
| Sep 30, 2022 | 1.96 Mn |
| Sep 30, 2022 | 1.96 Mn |
| Jun 30, 2022 | -2.42 Mn |
| Jun 30, 2022 | -2.42 Mn |
| Mar 31, 2022 | -1.87 Mn |
| Mar 31, 2022 | -1.87 Mn |
| Dec 31, 2021 | 2.36 Mn |
| Dec 31, 2021 | 2.36 Mn |
| Sep 30, 2021 | 2.58 Mn |
| Sep 30, 2021 | 2.58 Mn |
| Jun 30, 2021 | -3.13 Mn |
| Jun 30, 2021 | -3.13 Mn |
| Mar 31, 2021 | 1.84 Mn |
| Mar 31, 2021 | 1.84 Mn |
| Dec 31, 2020 | 229,000.00 |
| Dec 31, 2020 | 229,000.00 |
| Sep 30, 2020 | 578,000.00 |
| Sep 30, 2020 | 578,000.00 |
| Jun 30, 2020 | -1.71 Mn |
| Jun 30, 2020 | -1.71 Mn |
| Mar 31, 2020 | -4.32 Mn |
| Mar 31, 2020 | -4.32 Mn |
| Dec 31, 2019 | -6.21 Mn |
| Dec 31, 2019 | -6.21 Mn |
| Sep 30, 2019 | 3.63 Mn |
| Sep 30, 2019 | 3.63 Mn |
| Jun 30, 2019 | -386,000.00 |
| Jun 30, 2019 | -386,000.00 |
| Mar 31, 2019 | -197,000.00 |
| Mar 31, 2019 | -197,000.00 |
| Dec 31, 2018 | 1.03 Mn |
| Dec 31, 2018 | 1.03 Mn |
| Sep 30, 2018 | 1.24 Mn |
| Sep 30, 2018 | 1.24 Mn |
| Jun 30, 2018 | 4.38 Mn |
| Jun 30, 2018 | 4.38 Mn |
| Mar 31, 2018 | 316,000.00 |
| Mar 31, 2018 | 316,000.00 |
| Dec 31, 2017 | 1.43 Mn |
| Dec 31, 2017 | 1.43 Mn |
| Sep 30, 2017 | -31,000.00 |
| Sep 30, 2017 | -31,000.00 |
| Jun 30, 2017 | 2.33 Mn |
| Jun 30, 2017 | 2.33 Mn |
| Mar 31, 2017 | 831,000.00 |
| Mar 31, 2017 | 831,000.00 |
| Dec 31, 2016 | 895,000.00 |
| Dec 31, 2016 | 895,000.00 |
| Sep 30, 2016 | -1.58 Mn |
| Sep 30, 2016 | -1.58 Mn |
| Jun 30, 2016 | 485,000.00 |
| Jun 30, 2016 | 485,000.00 |
| Mar 31, 2016 | 2.01 Mn |
| Mar 31, 2016 | 2.01 Mn |
| Dec 31, 2015 | 132,000.00 |
| Dec 31, 2015 | 132,000.00 |
| Sep 30, 2015 | -43,000.00 |
| Sep 30, 2015 | -43,000.00 |
| Jun 30, 2015 | -833,000.00 |
| Jun 30, 2015 | -833,000.00 |
| Mar 31, 2015 | 385,000.00 |
| Mar 31, 2015 | 385,000.00 |
| Dec 31, 2014 | -101,000.00 |
| Dec 31, 2014 | -101,000.00 |